Location History:
- Weep, NL (2012)
- Weesp, NL (2002 - 2015)
Company Filing History:
7 out of 67 
2 out of 77 
1 out of 169 
Years Active: 2002-2015
Title: The Innovative Contributions of Bernard J Van Vliet
Introduction
Bernard J Van Vliet is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cannabinoid receptor modulators. With a total of 11 patents to his name, Van Vliet's work has the potential to impact various medical conditions.
Latest Patents
One of his latest patents involves 1H-imidazole derivatives as cannabinoid CB2 receptor modulators. This invention relates to a group of 1H-imidazole derivatives that serve as modulators of cannabinoid CB receptors. The patent details methods for the preparation of these compounds, novel intermediates useful for their synthesis, and pharmaceutical compositions containing these derivatives as active ingredients. These compositions are intended for the treatment of disorders involving cannabinoid CB receptors. Another significant patent focuses on 4,5-dihydro-(1H)-pyrazole derivatives as cannabinoid CB receptor modulators. This invention encompasses pharmaceutical compositions comprising these compounds, methods for their synthesis, and the therapeutic uses of these compounds in treating conditions such as multiple sclerosis, traumatic brain injury, chronic pain, and Alzheimer's disease.
Career Highlights
Throughout his career, Bernard J Van Vliet has worked with prominent companies in the pharmaceutical industry, including Solvay Pharmaceuticals B.V. and Solvay Pharmaceuticals GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Van Vliet has collaborated with notable colleagues such as Cornelis G Kruse and Josephus H M Lange. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Bernard J Van Vliet's innovative work in cannabinoid receptor modulation showcases his significant contributions to the field of pharmaceuticals. His patents reflect a commitment to advancing medical treatments for various disorders.